NovoRapid Caution For Usage

insulin aspart


Novo Nordisk


Full Prescribing Info
Caution For Usage
Special precautions for disposal and other handling: Needles and NovoRapid FlexPen must not be shared. The cartridge must not be refilled. NovoRapid must not be used if it does not appear clear and colourless or if it has been frozen.
The patient should be advised to discard the needle after each injection.
NovoRapid may be used in an infusion pump system (CSII) as described in Method of Administration under Dosage & Administration. Tubings in which the inner surface materials are made of polyethylene or polyolefin have been evaluated and found compatible with pump use.
In case of emergency in current NovoRapid users (hospitalisation or insulin pen malfunction), NovoRapid can be withdrawn with an U100 insulin syringe from FlexPen.
Incompatibilities: Substances added to NovoRapid may cause degradation of insulin aspart.
This product must not be diluted or mixed with other products, except infusion fluids as described in Dosage & Administration.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in